JP2013523677A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523677A5 JP2013523677A5 JP2013501780A JP2013501780A JP2013523677A5 JP 2013523677 A5 JP2013523677 A5 JP 2013523677A5 JP 2013501780 A JP2013501780 A JP 2013501780A JP 2013501780 A JP2013501780 A JP 2013501780A JP 2013523677 A5 JP2013523677 A5 JP 2013523677A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- levan
- solvent
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 17
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 claims 8
- 239000004480 active ingredient Substances 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 239000002904 solvent Substances 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 6
- 238000002360 preparation method Methods 0.000 claims 6
- 210000003296 saliva Anatomy 0.000 claims 6
- 239000011159 matrix material Substances 0.000 claims 5
- 239000012736 aqueous medium Substances 0.000 claims 4
- 239000007788 liquid Substances 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- FELGMEQIXOGIFQ-CYBMUJFWSA-N (3r)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one Chemical compound CC1=NC=CN1C[C@@H]1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-CYBMUJFWSA-N 0.000 claims 2
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 claims 2
- UCHDWCPVSPXUMX-TZIWLTJVSA-N Montelukast Chemical compound CC(C)(O)C1=CC=CC=C1CC[C@H](C=1C=C(\C=C\C=2N=C3C=C(Cl)C=CC3=CC=2)C=CC=1)SCC1(CC(O)=O)CC1 UCHDWCPVSPXUMX-TZIWLTJVSA-N 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 claims 2
- 229960001596 famotidine Drugs 0.000 claims 2
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 claims 2
- 229960003088 loratadine Drugs 0.000 claims 2
- 229960005127 montelukast Drugs 0.000 claims 2
- 229960005343 ondansetron Drugs 0.000 claims 2
- 238000000859 sublimation Methods 0.000 claims 2
- 230000008022 sublimation Effects 0.000 claims 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims 1
- FIEYHAAMDAPVCH-UHFFFAOYSA-N 2-methyl-1h-quinazolin-4-one Chemical group C1=CC=C2NC(C)=NC(=O)C2=C1 FIEYHAAMDAPVCH-UHFFFAOYSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229960004281 desmopressin Drugs 0.000 claims 1
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical group C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 claims 1
- 229960002845 desmopressin acetate Drugs 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 239000002075 main ingredient Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 239000006186 oral dosage form Substances 0.000 claims 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims 1
- 239000007892 solid unit dosage form Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN743/DEL/2010 | 2010-03-29 | ||
| IN743DE2010 | 2010-03-29 | ||
| PCT/EP2011/054699 WO2011120904A2 (en) | 2010-03-29 | 2011-03-28 | A fast dissolving pharmaceutical composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523677A JP2013523677A (ja) | 2013-06-17 |
| JP2013523677A5 true JP2013523677A5 (cg-RX-API-DMAC7.html) | 2014-04-24 |
| JP5736031B2 JP5736031B2 (ja) | 2015-06-17 |
Family
ID=44169174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013501780A Active JP5736031B2 (ja) | 2010-03-29 | 2011-03-28 | 速溶解性医薬組成物 |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US8946153B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2552418B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5736031B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101790188B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN102834091B (cg-RX-API-DMAC7.html) |
| AR (1) | AR080735A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011234637B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012024432A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2793485A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2643087T3 (cg-RX-API-DMAC7.html) |
| IL (2) | IL222087A (cg-RX-API-DMAC7.html) |
| MX (2) | MX341200B (cg-RX-API-DMAC7.html) |
| NZ (3) | NZ619857A (cg-RX-API-DMAC7.html) |
| PL (1) | PL2552418T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2566269C2 (cg-RX-API-DMAC7.html) |
| SA (1) | SA111320320B1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI498132B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011120904A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201207175B (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8318817B2 (en) | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| NZ619857A (en) | 2010-03-29 | 2015-05-29 | Ferring Bv | A fast dissolving pharmaceutical composition |
| JO3112B1 (ar) | 2010-03-29 | 2017-09-20 | Ferring Bv | تركيبة دوائية سريعة التحلل |
| US9731018B2 (en) * | 2011-09-16 | 2017-08-15 | Ferring B.V. | Fast dissolving pharmaceutical composition |
| AU2013289403B2 (en) | 2012-07-12 | 2017-05-11 | Ferring B.V. | Diclofenac formulations |
| TW201422254A (zh) * | 2012-11-21 | 2014-06-16 | Ferring Bv | 用於速釋及延釋的組成物 |
| WO2015063602A1 (en) * | 2013-10-29 | 2015-05-07 | Ferring B.V. | Desmopressin and blood glucose |
| EP3320908B1 (en) * | 2015-07-07 | 2023-09-06 | Toa Pharmaceutical Co., Ltd. | Bacteria-containing oral rapidly disintegrating tablet |
| US10172833B2 (en) | 2015-08-11 | 2019-01-08 | Insys Development Company, Inc. | Sublingual ondansetron spray |
| WO2017075554A1 (en) * | 2015-10-29 | 2017-05-04 | Golfetto Michael | Methods freeze drying and composite materials |
| US10952959B2 (en) | 2017-01-11 | 2021-03-23 | Ferring B.V. | Fast disintegrating pharmaceutical composition |
| US11278501B2 (en) | 2018-10-15 | 2022-03-22 | Aprecia Pharmaceuticals LLC | Method and system for forming a dosage form within a packaging |
| CN113750058B (zh) * | 2020-06-01 | 2023-07-04 | 北京九能天远科技有限公司 | 一种间苯三酚冻干口崩片及其制备方法 |
| WO2022069956A1 (en) | 2020-09-29 | 2022-04-07 | Millicent Pharma Limited | Orodispersible formulations |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| JP2023549568A (ja) | 2020-11-16 | 2023-11-27 | オルコサ・インコーポレイテッド | ヒトにおける治療的処置のための急速注入プラットフォーム及び組成物 |
| CN114010609A (zh) * | 2021-11-23 | 2022-02-08 | 莱默(北京)药业科技有限公司 | 一种孟鲁司特钠冻干口崩片及制备方法 |
| WO2024144674A1 (en) * | 2022-12-26 | 2024-07-04 | Atatürk Üni̇versi̇tesi̇ Fi̇kri̇ Mülki̇yet Haklari Koordi̇natörlüğü Döner Sermaye İşletmesi̇ | Orally disintegrating (odt) tablets formulations containing indomethacin and famotidine |
| WO2024150261A1 (en) * | 2023-01-10 | 2024-07-18 | Zarqa University | An oral pharmaceutical formulation and a method of preparation thereof |
| DE102023200788A1 (de) | 2023-01-31 | 2024-08-01 | Technische Universität Braunschweig - Körperschaft des öffentlichen Rechts | Festes Lyophilisat und Verfahren zur Herstellung |
| US20250114314A1 (en) * | 2023-10-05 | 2025-04-10 | Margo Harrison | Composition and method for treating menstruation related symptoms |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
| US4260602A (en) * | 1977-08-16 | 1981-04-07 | Burroughs Wellcome Co. | Hapten polysaccharide conjugate medicaments and method of use |
| CN1053808C (zh) | 1993-04-24 | 2000-06-28 | 章修纲 | 尼非地平控释剂型 |
| WO1998003184A1 (en) | 1996-07-19 | 1998-01-29 | Clarke-Garegg, Margaret, A. | Levan derivatives, their preparation, composition and applications including medical and food applications |
| TW362041B (en) * | 1996-12-27 | 1999-06-21 | Asahi Chemical Ind | Leakage inspection apparatus and method for filter film |
| EP0879600A1 (en) * | 1997-05-20 | 1998-11-25 | Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) | Fructan containing composition for the prevention and treatment of colon cancer |
| EP0958825A1 (en) | 1998-05-18 | 1999-11-24 | Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) | Synergistic composition of a non-digestible carbohydrate and an anti-cancer drug for use in the treatment of cancer |
| SE9803871D0 (sv) | 1998-11-11 | 1998-11-11 | Pharmacia & Upjohn Ab | Therapeutic method and formulation |
| AU1453600A (en) | 1998-11-04 | 2000-05-22 | Mcneil-Ppc, Inc. | Solid oral dosage forms containing alginic acid and famotidine |
| GB9901819D0 (en) | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
| GB9908014D0 (en) | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
| NL1012300C2 (nl) | 1999-06-11 | 2000-12-12 | Rijksuniversiteit | Stabilisator voor farmaca. |
| EP1064938A1 (en) | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
| CA2380449A1 (en) | 1999-08-17 | 2001-02-22 | Novartis Consumer Health S.A. | Rapidly dissolving dosage form and process for making same |
| WO2002003992A2 (en) | 2000-07-06 | 2002-01-17 | Wyeth | Use of substituted indole compounds for treating prosthesis-related bone degeneration |
| KR20030023697A (ko) | 2000-07-13 | 2003-03-19 | 다이이찌 세이야꾸 가부시기가이샤 | Ｄｄｓ 화합물을 함유하는 의약 조성물 |
| US6509040B1 (en) * | 2001-06-22 | 2003-01-21 | R.P. Scherer Corporation | Fast dispersing dosage forms essentially free of mammalian gelatin |
| MY148466A (en) | 2001-10-26 | 2013-04-30 | Merck Frosst Canada Ltd | Granule formulation |
| BR0308779A (pt) | 2002-04-03 | 2004-12-28 | Solvay Pharm Bv | Composição farmacêutica, e, método de preparação da mesma |
| GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| PT1501534E (pt) | 2002-05-07 | 2006-09-29 | Ferring Bv | Formulacoes farmaceuticas |
| US20040096569A1 (en) | 2002-11-15 | 2004-05-20 | Barkalow David G. | Edible film products and methods of making same |
| EP1428526A1 (en) * | 2002-12-13 | 2004-06-16 | Rijksuniversiteit Groningen | Formulation for fast dissolution of lipophilic compounds |
| MXPA05009079A (es) | 2003-02-28 | 2006-05-19 | Alk Abello As | Forma de dosificacion que tiene una matriz de sacarido. |
| US8012505B2 (en) | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| ATE387207T1 (de) * | 2003-09-05 | 2008-03-15 | Myung-Jun Chung | Zweifach coating-beschichteten milchsäurenbakterienpulver mit protein und polysaccharid und das verfahren zur deren herstellung sowie deren dosisform |
| CN100366294C (zh) | 2004-04-30 | 2008-02-06 | 量子高科（北京）研究院有限公司 | 一种口腔速溶制剂及其生产方法 |
| EP1597978A1 (en) * | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
| CN100339081C (zh) * | 2004-11-10 | 2007-09-26 | 范敏华 | 一种氯雷他定口腔崩解片剂的制备方法 |
| RU2007127999A (ru) * | 2004-12-23 | 2009-01-27 | МакНЕЙЛ-ППС, ИНК. (US) | Орально распадающееся фармацевтические композиции с сенсорными сигнальными агентами |
| US20070042023A1 (en) * | 2005-08-22 | 2007-02-22 | National Starch And Chemical Investment Holding Corporation | Dissolvable film |
| US8158152B2 (en) | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| ES2804472T3 (es) * | 2005-12-13 | 2021-02-08 | Harvard College | Estructuras para trasplante celular |
| TW200817049A (en) | 2006-06-05 | 2008-04-16 | Verus Pharmaceuticals Inc | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms |
| RU2009133376A (ru) * | 2007-03-27 | 2011-05-10 | Дзе Проктер Энд Гэмбл Компани (US) | Способы и наборы для введения пробиотиков |
| EP2170282A4 (en) | 2007-06-27 | 2014-11-05 | Hanmi Pharm Ind Co Ltd | METHOD FOR PRODUCING A QUICKLY CRUSHING FORMULATION FOR ORAL ADMINISTRATION AND DEVICE FOR PREPARING AND PACKAGING THE FORMULATION |
| KR100930427B1 (ko) * | 2008-01-25 | 2009-12-08 | 정명준 | 3중 코팅 유산균의 제조방법 및 나노 입자 코팅 방법, 그방법으로 제조된 3중 코팅 유산균 및 이를 포함하는 제품 |
| US8623401B2 (en) * | 2008-03-27 | 2014-01-07 | Fenwafe Inc. | Wafer formulation |
| NZ619857A (en) * | 2010-03-29 | 2015-05-29 | Ferring Bv | A fast dissolving pharmaceutical composition |
| US20120135050A1 (en) | 2010-07-08 | 2012-05-31 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
-
2011
- 2011-03-28 NZ NZ619857A patent/NZ619857A/en not_active IP Right Cessation
- 2011-03-28 BR BR112012024432A patent/BR112012024432A2/pt not_active IP Right Cessation
- 2011-03-28 AU AU2011234637A patent/AU2011234637B2/en not_active Ceased
- 2011-03-28 TW TW100110571A patent/TWI498132B/zh active
- 2011-03-28 NZ NZ602442A patent/NZ602442A/en not_active IP Right Cessation
- 2011-03-28 NZ NZ706991A patent/NZ706991A/en not_active IP Right Cessation
- 2011-03-28 WO PCT/EP2011/054699 patent/WO2011120904A2/en not_active Ceased
- 2011-03-28 CA CA2793485A patent/CA2793485A1/en not_active Abandoned
- 2011-03-28 CN CN201180017614.5A patent/CN102834091B/zh active Active
- 2011-03-28 EP EP11711321.7A patent/EP2552418B1/en active Active
- 2011-03-28 MX MX2012011205A patent/MX341200B/es active IP Right Grant
- 2011-03-28 ES ES11711321.7T patent/ES2643087T3/es active Active
- 2011-03-28 CN CN201510034145.8A patent/CN104606128B/zh active Active
- 2011-03-28 MX MX2016007895A patent/MX350447B/es unknown
- 2011-03-28 US US13/636,758 patent/US8946153B2/en active Active
- 2011-03-28 KR KR1020127027214A patent/KR101790188B1/ko not_active Expired - Fee Related
- 2011-03-28 JP JP2013501780A patent/JP5736031B2/ja active Active
- 2011-03-28 PL PL11711321T patent/PL2552418T3/pl unknown
- 2011-03-28 RU RU2012141140/15A patent/RU2566269C2/ru not_active IP Right Cessation
- 2011-03-29 SA SA111320320A patent/SA111320320B1/ar unknown
- 2011-03-29 AR ARP110101022A patent/AR080735A1/es unknown
-
2012
- 2012-09-23 IL IL222087A patent/IL222087A/en not_active IP Right Cessation
- 2012-09-25 ZA ZA2012/07175A patent/ZA201207175B/en unknown
-
2013
- 2013-07-26 US US13/952,084 patent/US9096335B2/en active Active
-
2014
- 2014-12-16 US US14/571,883 patent/US10023335B2/en active Active
-
2016
- 2016-08-02 IL IL247079A patent/IL247079A0/en unknown
-
2018
- 2018-06-16 US US16/010,412 patent/US20180297728A1/en not_active Abandoned